Terms: = Uterine cancer AND NTRK1, ENSG00000198400, 4914, P04629, TRK1, MTC, DKFZp781I14186, p140-TrkA, TRKA, TRK AND Prognosis
5 results:
1. Natural history and treatment efficacy in an ambispective case series of Ntrk-rearranged mesenchymal tumors.
Dufresne A; Pissaloux D; Ngo C; Penel N; Le Cesne A; Macagno N; Vanacker H; Hénon C; Jean-Denis M; Rughoo K; Tirode F; Blay JY; Brahmi M
ESMO Open; 2023 Apr; 8(2):101202. PubMed ID: 37054503
[TBL] [Abstract] [Full Text] [Related]
2. Adenoid Basal Carcinoma with Adenoid Cystic Carcinoma Component of the uterine Cervix: A Case Report and Literature Review.
Kitamura SI; Yoshida H; Kobayashi-Kato M; Kikkawa N; Tanase Y; Uno M; Ishikawa M; Kato T
Int J Surg Pathol; 2023 Aug; 31(5):819-824. PubMed ID: 36452999
[TBL] [Abstract] [Full Text] [Related]
3. Ntrk -Rearranged uterine Sarcomas: Clinicopathologic Features of 15 Cases, Literature Review, and Risk Stratification.
Costigan DC; Nucci MR; Dickson BC; Chang MC; Song S; Sholl LM; Hornick JL; Fletcher CDM; Kolin DL
Am J Surg Pathol; 2022 Oct; 46(10):1415-1429. PubMed ID: 35713627
[TBL] [Abstract] [Full Text] [Related]
4. [Endometrial and other rare uterine sarcomas : Diagnostic aspects in the context of the 2020 WHO classification].
Mayr D; Horn LC; Hiller GGR; Höhn AK; Schmoeckel E
Pathologe; 2022 May; 43(3):183-195. PubMed ID: 35362728
[TBL] [Abstract] [Full Text] [Related]
5. Transcriptome profiling of gastric-type endocervical adenocarcinomas identifies key signaling pathways for tumor progression.
Vasseur D; Lopez J; Croce S; Tondeur G; Bonin L; Descotes F; Golfier F; Devouassoux-Shisheboran M
Gynecol Oncol; 2020 Jun; 157(3):775-782. PubMed ID: 32317172
[TBL] [Abstract] [Full Text] [Related]
